Theradaptive Gains FDA Approval for Regenerative Spine Therapy
FREDERICK, MARYLAND, April 30, 2026 Theradaptive has received U.S. Food and Drug Administration (FDA) authorization to advance its OASIS...
spinal fusion
Advertisement
CGBIO Wins FDA IDE for NOVOSIS PUTTY Spine Trial
Seoul, South Korea | April 24, 2025 CGBIO has achieved a major regulatory milestone with the U.S. Food and...
Cerapedics Expands PearlMatrix Access via Vizient Deal
Westminster, Colorado | April 24, 2026 Cerapedics has announced a strategic supplier agreement with Vizient, significantly expanding access to...
Spine Innovation Wins FDA 510(k) for LOGIC™ Implant System
CORONADO, CALIFORNIA | January 26, 2026 — Spine Innovation, LLC announced it has received FDA 510(k) clearance to market...
Advertisement
